Compare TXG & AMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TXG | AMG |
|---|---|---|
| Founded | 2012 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 10.0B |
| IPO Year | 2019 | 1997 |
| Metric | TXG | AMG |
|---|---|---|
| Price | $63.80 | $358.94 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 4 |
| Target Price | $20.25 | ★ $384.00 |
| AVG Volume (30 Days) | ★ 3.0M | 240.6K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.01% |
| EPS Growth | ★ 76.97 | 50.30 |
| EPS | N/A | ★ 10.76 |
| Revenue | $245,893,000.00 | ★ $2,074,400,000.00 |
| Revenue This Year | N/A | $11.98 |
| Revenue Next Year | $7.33 | $9.34 |
| P/E Ratio | ★ N/A | $33.11 |
| Revenue Growth | ★ 68.06 | 1.64 |
| 52 Week Low | $11.17 | $223.44 |
| 52 Week High | $65.47 | $392.92 |
| Indicator | TXG | AMG |
|---|---|---|
| Relative Strength Index (RSI) | 71.19 | 48.76 |
| Support Level | $17.54 | $331.16 |
| Resistance Level | N/A | $363.89 |
| Average True Range (ATR) | 3.95 | 10.41 |
| MACD | 0.67 | -2.20 |
| Stochastic Oscillator | 93.26 | 23.07 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Affiliated Managers Group offers investment strategies to investors through its network of affiliates. The firm typically buys a majority interest in small to mid-size boutique asset managers, receiving a fixed percentage of revenue from these firms in return. Affiliates operate independently, with AMG providing strategic, operational, and technology support, as well as global distribution. At the end of March 2026, AMG's affiliate network—which includes firms like Abacus Capital and Pantheon dedicated to private markets (which accounted for 17% of AUM), AQR Capital and Capula Investment Management in liquid alternatives (29%), and Harding Loevner, Tweedy Browne, Parnassus, and Yacktman in equities, multi-asset, and bond strategies (54%)—had $882.0 billion in managed assets.